Advisory Research’s Loxo Oncology, Inc LOXO Stock Holding History

Advisory Research’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,028	Closed	-$1.41M	–	404
2018 Q4	$1.41M	Buy	10,028 +243	+2%	+$36.9K	0.03%	203
2018 Q3	$1.67M	Sell	9,785 -20	-0.2%	-$3.36K	0.03%	213
2018 Q2	$1.7M	Sell	9,805 -5,932	-38%	-$891K	0.03%	223
2018 Q1	$1.82M	Sell	15,737 -9,523	-38%	-$1.01M	0.03%	219
2017 Q4	$2.13M	Sell	25,260 -4,701	-16%	-$392K	0.04%	215
2017 Q3	$2.76M	Buy	29,961 +9,240	+45%	+$718K	0.04%	185
2017 Q2	$1.66M	Sell	20,721 -3,698	-15%	-$205K	0.03%	244
2017 Q1	$1.03M	Buy	+24,419	New	+$1.01M	0.02%	320

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Advisory Research's LOXO Position: Q1 2019 in Review

Advisory Research sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 10,028 shares — an estimated $1.41M sold.

Advisory Research first reported a position in LOXO in Q1 2017 and held it in 8 quarters. The position peaked at $2.76M in Q3 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Advisory Research reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Advisory Research sold 10,028 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.41M.
Advisory Research first reported a position in Loxo Oncology, Inc in Q1 2017 and held it in 8 quarters.
Advisory Research's Loxo Oncology, Inc position peaked at $2.76M in Q3 2017.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Advisory Research's 13F filing for Q1 2019, filed 15 May 2019.